A race creates mostly losers. A journey to improvement creates standards, fosters collaboration, and recognizes boundaries. Why the long road still matters. Dr. Kingsley R. Chin MD, MBA Professor, Orthopedic Spine Surgery | CEO KIC Ventures Dr. Jason A Seale MBA The Beginning of Sacrix In 2013, sacroiliac joint fusion was not widely adopted. This is where the Sacrix journey began. A different path was taken. Patents were filed on multithreaded designs for Sacrix. A 100% fluoroscopic...

From Spinal Fusion to Anatomy & Motion Preservation: Redefining the Future of Outpatient Interventional Spine Surgery. Dr. Kingsley R. Chin MD, MBA Professor, Orthopedic Spine Surgery | CEO KIC Ventures Dr. Jason A Seale MBA Nothing else in the world… not all the armies… is so powerful as an idea whose time has come.”— Victor Hugo Have you ever wondered why spine surgeons admire fixing the X-ray? Why do so many patients — even with great post-operative X-rays — still end up needing revision...

In 1969, a Vietnam War–driven medical challenge led Dr. Larry Hench to develop 45S5 bioactive glass — the first synthetic material to bond directly with living bone. This breakthrough shifted biomaterials from inert implants to regenerative medicine. Acquired by KIC Ventures in 2018, NanoFUSE Biologics is advancing next-generation synthetic biologics to support bone regeneration in modern spine and orthopedic care.